The global Cosmetic Peptide Manufacturing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
Publisher' newest research report, the “Cosmetic Peptide Manufacturing Industry Forecast” looks at past sales and reviews total world Cosmetic Peptide Manufacturing sales in 2023, providing a comprehensive analysis by region and market sector of projected Cosmetic Peptide Manufacturing sales for 2024 through 2030. With Cosmetic Peptide Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cosmetic Peptide Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Cosmetic Peptide Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cosmetic Peptide Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cosmetic Peptide Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cosmetic Peptide Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cosmetic Peptide Manufacturing.
United States market for Cosmetic Peptide Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cosmetic Peptide Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cosmetic Peptide Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cosmetic Peptide Manufacturing players cover Croda International PIc, Ashland, DSM [Koninklijke DSM NV], Bachem and Genscript Biotech Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Peptide Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by type
Signal Peptides
Neurotransmitter Inhibitors
Carrier Peptides
Enzyme Inhibitor Peptides
Structural Peptides
Synthetic Antimicrobial Peptides (Amps)
Others
Segmentation by application
Cosmetic Manufacturers
Cosmetic Contract Manufacturers
Biopharmaceutical Industries (Personal Care)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Croda International PIc
Ashland
DSM [Koninklijke DSM NV]
Bachem
Genscript Biotech Corp
BASF SE
Geltor
The Lubrizol Corporation
Symrise
Bio basic Inc.
Regeron Inc.
Merck KGaA
RS Synthesis, LLC
CSBio Company Inc.
Creative Peptides
Spec Chem Industry Inc.
LipoTrue, SL
Fibroheal
Seiwa Kasei Co., Ltd.
Silab
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cosmetic Peptide Manufacturing Market Size 2019-2030
2.1.2 Cosmetic Peptide Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cosmetic Peptide Manufacturing Segment by Type
2.2.1 Signal Peptides
2.2.2 Neurotransmitter Inhibitors
2.2.3 Carrier Peptides
2.2.4 Enzyme Inhibitor Peptides
2.2.5 Structural Peptides
2.2.6 Synthetic Antimicrobial Peptides (Amps)
2.2.7 Others
2.3 Cosmetic Peptide Manufacturing Market Size by Type
2.3.1 Cosmetic Peptide Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cosmetic Peptide Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Cosmetic Peptide Manufacturing Segment by Application
2.4.1 Cosmetic Manufacturers
2.4.2 Cosmetic Contract Manufacturers
2.4.3 Biopharmaceutical Industries (Personal Care)
2.5 Cosmetic Peptide Manufacturing Market Size by Application
2.5.1 Cosmetic Peptide Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cosmetic Peptide Manufacturing Market Size Market Share by Application (2019-2024)
3 Cosmetic Peptide Manufacturing Market Size by Player
3.1 Cosmetic Peptide Manufacturing Market Size Market Share by Players
3.1.1 Global Cosmetic Peptide Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Cosmetic Peptide Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Cosmetic Peptide Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cosmetic Peptide Manufacturing by Regions
4.1 Cosmetic Peptide Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Cosmetic Peptide Manufacturing Market Size Growth (2019-2024)
4.3 APAC Cosmetic Peptide Manufacturing Market Size Growth (2019-2024)
4.4 Europe Cosmetic Peptide Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Cosmetic Peptide Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cosmetic Peptide Manufacturing Market Size by Country (2019-2024)
5.2 Americas Cosmetic Peptide Manufacturing Market Size by Type (2019-2024)
5.3 Americas Cosmetic Peptide Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cosmetic Peptide Manufacturing Market Size by Region (2019-2024)
6.2 APAC Cosmetic Peptide Manufacturing Market Size by Type (2019-2024)
6.3 APAC Cosmetic Peptide Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cosmetic Peptide Manufacturing by Country (2019-2024)
7.2 Europe Cosmetic Peptide Manufacturing Market Size by Type (2019-2024)
7.3 Europe Cosmetic Peptide Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cosmetic Peptide Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Cosmetic Peptide Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cosmetic Peptide Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cosmetic Peptide Manufacturing Market Forecast
10.1 Global Cosmetic Peptide Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Cosmetic Peptide Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Cosmetic Peptide Manufacturing Forecast
10.1.3 APAC Cosmetic Peptide Manufacturing Forecast
10.1.4 Europe Cosmetic Peptide Manufacturing Forecast
10.1.5 Middle East & Africa Cosmetic Peptide Manufacturing Forecast
10.2 Americas Cosmetic Peptide Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Cosmetic Peptide Manufacturing Market Forecast
10.2.2 Canada Cosmetic Peptide Manufacturing Market Forecast
10.2.3 Mexico Cosmetic Peptide Manufacturing Market Forecast
10.2.4 Brazil Cosmetic Peptide Manufacturing Market Forecast
10.3 APAC Cosmetic Peptide Manufacturing Forecast by Region (2025-2030)
10.3.1 China Cosmetic Peptide Manufacturing Market Forecast
10.3.2 Japan Cosmetic Peptide Manufacturing Market Forecast
10.3.3 Korea Cosmetic Peptide Manufacturing Market Forecast
10.3.4 Southeast Asia Cosmetic Peptide Manufacturing Market Forecast
10.3.5 India Cosmetic Peptide Manufacturing Market Forecast
10.3.6 Australia Cosmetic Peptide Manufacturing Market Forecast
10.4 Europe Cosmetic Peptide Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Cosmetic Peptide Manufacturing Market Forecast
10.4.2 France Cosmetic Peptide Manufacturing Market Forecast
10.4.3 UK Cosmetic Peptide Manufacturing Market Forecast
10.4.4 Italy Cosmetic Peptide Manufacturing Market Forecast
10.4.5 Russia Cosmetic Peptide Manufacturing Market Forecast
10.5 Middle East & Africa Cosmetic Peptide Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Cosmetic Peptide Manufacturing Market Forecast
10.5.2 South Africa Cosmetic Peptide Manufacturing Market Forecast
10.5.3 Israel Cosmetic Peptide Manufacturing Market Forecast
10.5.4 Turkey Cosmetic Peptide Manufacturing Market Forecast
10.5.5 GCC Countries Cosmetic Peptide Manufacturing Market Forecast
10.6 Global Cosmetic Peptide Manufacturing Forecast by Type (2025-2030)
10.7 Global Cosmetic Peptide Manufacturing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Croda International PIc
11.1.1 Croda International PIc Company Information
11.1.2 Croda International PIc Cosmetic Peptide Manufacturing Product Offered
11.1.3 Croda International PIc Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Croda International PIc Main Business Overview
11.1.5 Croda International PIc Latest Developments
11.2 Ashland
11.2.1 Ashland Company Information
11.2.2 Ashland Cosmetic Peptide Manufacturing Product Offered
11.2.3 Ashland Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ashland Main Business Overview
11.2.5 Ashland Latest Developments
11.3 DSM [Koninklijke DSM NV]
11.3.1 DSM [Koninklijke DSM NV] Company Information
11.3.2 DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Product Offered
11.3.3 DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DSM [Koninklijke DSM NV] Main Business Overview
11.3.5 DSM [Koninklijke DSM NV] Latest Developments
11.4 Bachem
11.4.1 Bachem Company Information
11.4.2 Bachem Cosmetic Peptide Manufacturing Product Offered
11.4.3 Bachem Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bachem Main Business Overview
11.4.5 Bachem Latest Developments
11.5 Genscript Biotech Corp
11.5.1 Genscript Biotech Corp Company Information
11.5.2 Genscript Biotech Corp Cosmetic Peptide Manufacturing Product Offered
11.5.3 Genscript Biotech Corp Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genscript Biotech Corp Main Business Overview
11.5.5 Genscript Biotech Corp Latest Developments
11.6 BASF SE
11.6.1 BASF SE Company Information
11.6.2 BASF SE Cosmetic Peptide Manufacturing Product Offered
11.6.3 BASF SE Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BASF SE Main Business Overview
11.6.5 BASF SE Latest Developments
11.7 Geltor
11.7.1 Geltor Company Information
11.7.2 Geltor Cosmetic Peptide Manufacturing Product Offered
11.7.3 Geltor Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Geltor Main Business Overview
11.7.5 Geltor Latest Developments
11.8 The Lubrizol Corporation
11.8.1 The Lubrizol Corporation Company Information
11.8.2 The Lubrizol Corporation Cosmetic Peptide Manufacturing Product Offered
11.8.3 The Lubrizol Corporation Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 The Lubrizol Corporation Main Business Overview
11.8.5 The Lubrizol Corporation Latest Developments
11.9 Symrise
11.9.1 Symrise Company Information
11.9.2 Symrise Cosmetic Peptide Manufacturing Product Offered
11.9.3 Symrise Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Symrise Main Business Overview
11.9.5 Symrise Latest Developments
11.10 Bio basic Inc.
11.10.1 Bio basic Inc. Company Information
11.10.2 Bio basic Inc. Cosmetic Peptide Manufacturing Product Offered
11.10.3 Bio basic Inc. Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio basic Inc. Main Business Overview
11.10.5 Bio basic Inc. Latest Developments
11.11 Regeron Inc.
11.11.1 Regeron Inc. Company Information
11.11.2 Regeron Inc. Cosmetic Peptide Manufacturing Product Offered
11.11.3 Regeron Inc. Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Regeron Inc. Main Business Overview
11.11.5 Regeron Inc. Latest Developments
11.12 Merck KGaA
11.12.1 Merck KGaA Company Information
11.12.2 Merck KGaA Cosmetic Peptide Manufacturing Product Offered
11.12.3 Merck KGaA Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Merck KGaA Main Business Overview
11.12.5 Merck KGaA Latest Developments
11.13 RS Synthesis, LLC
11.13.1 RS Synthesis, LLC Company Information
11.13.2 RS Synthesis, LLC Cosmetic Peptide Manufacturing Product Offered
11.13.3 RS Synthesis, LLC Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 RS Synthesis, LLC Main Business Overview
11.13.5 RS Synthesis, LLC Latest Developments
11.14 CSBio Company Inc.
11.14.1 CSBio Company Inc. Company Information
11.14.2 CSBio Company Inc. Cosmetic Peptide Manufacturing Product Offered
11.14.3 CSBio Company Inc. Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 CSBio Company Inc. Main Business Overview
11.14.5 CSBio Company Inc. Latest Developments
11.15 Creative Peptides
11.15.1 Creative Peptides Company Information
11.15.2 Creative Peptides Cosmetic Peptide Manufacturing Product Offered
11.15.3 Creative Peptides Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Creative Peptides Main Business Overview
11.15.5 Creative Peptides Latest Developments
11.16 Spec Chem Industry Inc.
11.16.1 Spec Chem Industry Inc. Company Information
11.16.2 Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Product Offered
11.16.3 Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Spec Chem Industry Inc. Main Business Overview
11.16.5 Spec Chem Industry Inc. Latest Developments
11.17 LipoTrue, SL
11.17.1 LipoTrue, SL Company Information
11.17.2 LipoTrue, SL Cosmetic Peptide Manufacturing Product Offered
11.17.3 LipoTrue, SL Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 LipoTrue, SL Main Business Overview
11.17.5 LipoTrue, SL Latest Developments
11.18 Fibroheal
11.18.1 Fibroheal Company Information
11.18.2 Fibroheal Cosmetic Peptide Manufacturing Product Offered
11.18.3 Fibroheal Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Fibroheal Main Business Overview
11.18.5 Fibroheal Latest Developments
11.19 Seiwa Kasei Co., Ltd.
11.19.1 Seiwa Kasei Co., Ltd. Company Information
11.19.2 Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Product Offered
11.19.3 Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Seiwa Kasei Co., Ltd. Main Business Overview
11.19.5 Seiwa Kasei Co., Ltd. Latest Developments
11.20 Silab
11.20.1 Silab Company Information
11.20.2 Silab Cosmetic Peptide Manufacturing Product Offered
11.20.3 Silab Cosmetic Peptide Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Silab Main Business Overview
11.20.5 Silab Latest Developments
12 Research Findings and Conclusion
*If Applicable.